famotidine has been researched along with Idiopathic Parkinson Disease in 3 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seven patients with idiopathic Parkinson's disease were enrolled in a ten week study to evaluate the efficacy of famotidine, an histamine H2-antagonist, in the treatment of bradyphrenia." | 2.68 | The use of famotidine in the treatment of Parkinson's disease: a pilot study. ( Di Rocco, A; Kaminski, R; Molinari, SP; Yahr, MD, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, SAO | 1 |
| Xia, R | 1 |
| Ding, Y | 1 |
| Won, L | 1 |
| Ray, WJ | 1 |
| Hitchcock, SA | 1 |
| McGehee, DS | 1 |
| Kang, UJ | 1 |
| Molinari, SP | 1 |
| Kaminski, R | 1 |
| Di Rocco, A | 1 |
| Yahr, MD | 1 |
| Katsumata, S | 1 |
| Mizuno, S | 1 |
| Shirata, A | 1 |
| Yamane, K | 1 |
1 trial available for famotidine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The use of famotidine in the treatment of Parkinson's disease: a pilot study.
Topics: Aged; Cognition; Famotidine; Histamine H2 Antagonists; Humans; Middle Aged; Neuropsychological Tests | 1995 |
2 other studies available for famotidine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia.
Topics: Action Potentials; Animals; Cholinergic Neurons; Corpus Striatum; Dicyclomine; Disease Models, Anima | 2015 |
[Famotidine induced parkinsonism in a case of essential tremor].
Topics: Aged; Essential Tremor; Famotidine; Female; Histamine H2 Antagonists; Humans; Parkinson Disease | 2002 |